Maison des Adolescents, Mulhouse, France; CAMUHA, University of Upper Alsace, Mulhouse, France.
Dialogues Clin Neurosci. 2020 Sep;22(3):223-228. doi: 10.31887/DCNS.2020.22.3/mcrocq.
This article retraces the story of cannabis from the earliest contacts of humans with the plant to its subsequent global expansion, its medicinal uses, and the discovery of the endocannabinoid system in the 20 century. Cannabis was attested to around 12 000 years ago near the Altai Mountains in Central Asia, and since then, cannabis seeds have accompanied the migration of nomadic peoples. Records of the medicinal use of cannabis appear before the Common Era in China, Egypt, and Greece (Herodotus), and later in the Roman empire (Pliny the Elder, Dioscorides, Galen). In the 19 century, orientalists like Silvestre de Sacy, and Western physicians coming into contact with Muslim and Indian cultures, like O'Shaughnessy and Moreau de Tours, introduced the medicinal use of cannabis into Europe. The structure of the main psychoactive phytocannabinoid, tetrahydrocannabinol (THC), was determined in Israel by Mechoulam and Gaoni in 1964. This discovery opened the gate for many of the subsequent developments in the field of endocannabinoid system (ECS) research. The advances in the scientific knowledge of the ECS place the debate on cannabis liberalization in a new context. .
本文追溯了大麻从人类与植物最早接触到随后的全球扩张、药用用途,以及 20 世纪发现内源性大麻素系统的历史。大约在 12000 年前,大麻在中亚的阿尔泰山脉附近被发现,从那时起,大麻种子就伴随着游牧民族的迁徙。大麻的药用记载可以追溯到公元前的中国、埃及和希腊(希罗多德),以及后来的罗马帝国(老普林尼、迪奥斯科里德斯、盖伦)。19 世纪,像西尔维斯特·德·萨西(Silvestre de Sacy)这样的东方学家,以及像奥肖内西(O'Shaughnessy)和莫罗·德·图尔(Moreau de Tours)这样接触过穆斯林和印度文化的西方医生,将大麻的药用用途引入了欧洲。1964 年,以色列的迈赫鲁姆(Mechoulam)和高尼(Gaoni)确定了主要精神活性植物大麻素四氢大麻酚(THC)的结构。这一发现为内源性大麻素系统(ECS)研究领域的许多后续发展打开了大门。ECS 科学知识的进步使关于大麻合法化的辩论进入了一个新的背景。